| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Chief Accounting Officer | VP, CAO &Corporate Controller
1 company
Winters Chad serves as a VP, Chief Accounting Officer at WST. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $527K at current prices.
Historically, Winters Chad's trades have earned a middling insider score of 58/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +21.4%.
The biggest single holding is WST (~$527K) as VP, Chief Accounting Officer. The recent filings there lean toward selling, a net 2,724 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | WST West Pharmaceutical Services, Inc. | VP, Chief Accounting Officer | Sale+OE | 896 | $300.67 | $269,399.24 | -37.0% | +8.6% | - | |
| Mar 11, 2024 | WST West Pharmaceutical Services Inc | VP, Chief Accounting Officer | Sale+OE | 815 | $358.82 | $292,435.86 | -38.4% | -10.5% | -35.5% | |
| Dec 1, 2023 | WST West Pharmaceutical Services Inc | VP, Chief Accounting Officer | Sale+OE | 1,013 | $349.00 | $353,541.25 | -44.4% | +1.9% | -7.4% |